Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Omeros Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
OMER
Nasdaq
8731
https://www.omeros.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Omeros Corp
Q4 2023 Omeros Corp Earnings Call
- Apr 2nd, 2024 4:41 pm
Omeros Corporation (NASDAQ:OMER) Q4 2023 Earnings Call Transcript
- Apr 2nd, 2024 3:22 pm
Omeros Corp (OMER) Reports Fourth Quarter and Year-End 2023 Financial Results
- Apr 1st, 2024 9:32 pm
Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
- Apr 1st, 2024 8:02 pm
Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
- Mar 27th, 2024 12:30 pm
Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade
- Mar 17th, 2024 2:02 pm
Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
- Feb 20th, 2024 2:00 pm
3 Sleeper Stocks Under $15 Ready to Explode by 2029
- Feb 7th, 2024 2:34 pm
Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
- Feb 1st, 2024 2:11 pm
Institutions profited after Omeros Corporation's (NASDAQ:OMER) market cap rose US$23m last week but individual investors profited the most
- Jan 22nd, 2024 11:45 am
Brian's Big Idea on Biotech
- Jan 10th, 2024 1:01 am
7 Short-Squeeze Stocks That Are Screaming for Speculation
- Dec 24th, 2023 6:08 pm
Omeros Corporation (NASDAQ:OMER) Q3 2023 Earnings Call Transcript
- Nov 11th, 2023 8:01 pm
Q3 2023 Omeros Corp Earnings Call
- Nov 10th, 2023 2:43 pm
Omeros Corporation Reports Third Quarter 2023 Financial Results
- Nov 9th, 2023 9:02 pm
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023
- Nov 6th, 2023 1:00 pm
Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
- Nov 3rd, 2023 1:05 pm
Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting
- Nov 2nd, 2023 1:05 pm
Omeros Corporation Hires Andreas Grauer M.D. as Chief Medical Officer
- Oct 19th, 2023 12:30 pm
UPDATE 1-Omeros to terminate kidney disease trial as therapy fails late-stage study
- Oct 16th, 2023 11:59 am
Scroll